LimmaTech Biologics
PrivateLast Round
Grant
Feb 17, 2025
Total Funding Raised
$51.87M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
LimmaTech Biologics is a biopharmaceutical company that specializes in the research, development, and production of innovative bioconjugate vaccines to prevent life-threatening diseases caused by antimicrobial-resistant pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LimmaTech Biologics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
LimmaTech Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2025 | ||||
| Grant | Feb 27, 2024 | ||||
| Series A Extension | Feb 1, 2024 | ||||
| Series A | Oct 9, 2023 | ||||
| Seed | Oct 1, 2017 |
Key People
Founding team and executive leadership
LimmaTech Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| AXA IM Alts | Series A Extension, Series A |
| Novo Holdings | Series A |
| BNP Paribas Asset Management | Series A |
| AXA Investment Managers | Series A |
| Adjuvant Capital | Series A Extension, Series A |
| Tenmile | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 74% MoM, reaching 1K.
- Apr 10, 2025
Partnering with Valneva to co-develop S4V2 vaccine.
LimmaTech Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LimmaTech Biologics's valuation, stock price, and market status.